Quality Systems – Page 71

Post-approval change misclassified during agency query response – FDA/EMA expectations and how to respond

“`html Responding to Misclassified Post-Approval Changes During Regulatory Queries In today’s fast-paced pharmaceutical landscape, maintaining compliance with regulatory bodies such as the FDA, EMA, and MHRA is paramount. One of…

Spare part not qualified during inspection walkthrough – CAPA that links maintenance to product quality risk

“`html Addressing Unqualified Spare Parts as a Quality Risk during Inspection Walkthroughs When conducting inspection walkthroughs in pharmaceutical manufacturing, the presence of unqualified spare parts can lead to significant quality…

Submission delayed due to data gaps during variation planning – documentation gaps inspectors question

Addressing Delays in Submission Due to Documentation Gaps in Variation Planning In the highly regulated pharmaceutical industry, maintaining compliance is crucial for successful product lifecycle management. A frequent issue encountered…

CMMS records incomplete during changeover maintenance – CAPA that links maintenance to product quality risk

“`html Addressing Incomplete CMMS Records During Changeover Maintenance: A Comprehensive CAPA Approach In pharmaceutical manufacturing, the integrity of equipment maintenance records is pivotal to ensuring product quality and compliance with…

Deficiency response rejected by agency during agency query response – FDA/EMA expectations and how to respond

Responding to a Rejected Deficiency Response During Agency Queries: A Comprehensive Investigation Guide In the highly regulated pharmaceutical landscape, receiving a rejection on a deficiency response from an agency such…

Spare part not qualified during routine operations – GMP documentation expectations for engineering teams

Investigating Unqualified Spare Parts During Routine Operations in Pharma Manufacturing In pharmaceutical manufacturing, the qualification of spare parts is paramount to maintaining the integrity of the processes and products. However,…

CMC section queries unresolved during lifecycle management – documentation gaps inspectors question

“`html Addressing Unresolved CMC Section Queries in Lifecycle Management: An Investigative Approach In the pharmaceutical industry, unresolved Chemistry, Manufacturing, and Controls (CMC) section queries can lead to serious compliance concerns…

Spare part not qualified during shutdown and restart – calibration/PM evidence pack checklist

Investigation into Unqualified Spare Parts During Shutdown and Restart Procedures In the pharmaceutical manufacturing environment, the qualification of spare parts during shutdown and restart procedures is critical. Failure to qualify…

Post-approval change misclassified during lifecycle management – FDA/EMA expectations and how to respond

Investigation of Misclassified Post-approval Changes in Lifecycle Management In the highly regulated pharmaceutical landscape, misclassifying post-approval changes during lifecycle management can lead to significant compliance issues and regulatory scrutiny. This…

Calibration failure discovered during changeover maintenance – calibration/PM evidence pack checklist

Addressing Calibration Failures Encountered During Changeover Maintenance In the dynamic environment of pharmaceutical manufacturing, deviations in calibration can significantly impact product quality, compliance, and operational efficiency. Calibration failures discovered during…

Post-approval change misclassified during variation planning – how to avoid repeat deficiencies

“`html How to Prevent Misclassification of Post-approval Changes During Variation Planning The lifecycle of a pharmaceutical product demands rigorous management of changes to maintain compliance with regulatory expectations. Misclassifying a…

Preventive maintenance overdue during changeover maintenance – calibration/PM evidence pack checklist

Addressing Preventive Maintenance Overdue During Changeover Maintenance In the highly regulated pharmaceutical manufacturing environment, failure to complete preventive maintenance (PM) on time can devolve into quality issues, operational disruptions, and…